/PRNewswire/ Concept Medical Inc. (CMI), on 9th February 2023, received the Investigational Device Exemption (IDE) from the US FDA, for its Magic Touch.
Get latest articles and stories on Business at LatestLY. Concept Medical Inc. (CMI), on 9th February 2023, received the Investigational Device Exemption (IDE) from the US FDA, for its Magic Touch Sirolimus Coated Balloon. Business News | Concept Medical Granted Investigational Device Exemption (IDE) Approval for Their Magic Touch Sirolimus Coated Balloon for the Treatment of Below the Knee (BTK) Arterial Disease.